Spots Global Cancer Trial Database for Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)
Official Title: Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥75 Years)
Study ID: NCT00812864
Interventions
Study Description
Brief Summary: The aim of the study is to determine blood concentration evolution of capecitabine and its active metabolites, in elderly patient 75 years and more.
Detailed Description: Blood samples will be taken before 1rst course of chemotherapy of capécitabine for colorectal or breast metastatic cancer. Pharmacokinetic will be realizes at several times (H0,5, H1, H1,5, H2, H4, H6, H8) and repeated at D14 of the 2d cycle
Eligibility
Minimum Age: 75 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHU Limoges, Limoges Cedex, Province, France
Contact Details
Name: Nicole TUBIANA-MATHIEU, MD
Affiliation: CHU de Limoges, medical oncology department ,02 avenue Martin Luther King 87042 Limoges cedex France
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
